On Chemball
My Chemball
+86-571-8627 3270
Kaifeng Mingren Pharmaceutical Co.,LTD.
Kaifeng Mingren Pharmaceutical Co.,LTD.
Main Products:
Phloroglucinol Anhydrous / Phlorglucinol Dihydrate / Vidarabine Monophosphate / Creatine Phosphate Disodium Salt / 2-[4-(1,3-Benzodioxol-5-Ylmethyl)Piperazin-1-Yl]Pyrimidine / Guanfacine Hydrochloride###Guanfacine Hcl / Fomepizole / Nitisinone / Epalrestat / Nafamostat Mesylate / Doxofylline / (S)-3-Cyano-5-Methylhexanoic Acid Ethyl Ester / 4-(6-Fluoropyridin-3-yl)-6-(2-Hydroxy-2-Methylpropoxy)Pyrazolo[1,5-a]Pyridine-3-Carbonitrile / Methyl 5-((4-Bromo-2-Chlorophenyl)Amino)-4-Fluoro-1-Methyl-1H-Benzo[d]Imidazole-6-Carboxylate / Benzyl (3R,4S)-3-(2-Bromoacetyl)-4-Ethylpyrrolidine-1-Carboxylate / 5-Bromo-4,7-Diazaindole / (2R,3R)-3-(2,5-Difluorophenyl)-3-Hydroxy-2-Methyl-4-(1H-1,2,4-Triazol-1-yl)Butanethioamide / 4-(2-Bromoacetyl)Benzonitrile / Isavuconazole
Phloroglucinol anhydrous
Phlorglucinol Dihydrate
Vidarabine Monophosphate
Creatine Phosphate Disodium Salt
2-[4-(1,3-Benzodioxol-5-Ylmethyl)Piperazin-1-Yl]Pyrimidine
Guanfacine Hydrochloride###Guanfacine Hcl
Fomepizole
Nitisinone
Epalrestat
Nafamostat Mesylate
Doxofylline
(S)-3-Cyano-5-Methylhexanoic Acid Ethyl Ester
4-(6-Fluoropyridin-3-yl)-6-(2-Hydroxy-2-Methylpropoxy)Pyrazolo[1,5-a]Pyridine-3-Carbonitrile
Methyl 5-((4-Bromo-2-Chlorophenyl)Amino)-4-Fluoro-1-Methyl-1H-Benzo[d]Imidazole-6-Carboxylate
Benzyl (3R,4S)-3-(2-Bromoacetyl)-4-Ethylpyrrolidine-1-Carboxylate
5-Bromo-4,7-Diazaindole
(2R,3R)-3-(2,5-Difluorophenyl)-3-Hydroxy-2-Methyl-4-(1H-1,2,4-Triazol-1-yl)Butanethioamide
4-(2-Bromoacetyl)Benzonitrile
Isavuconazole
ABOUT US
Kaifeng Mingren Pharmaceutical Co.,LTD. was Established in 2002 with Registered capital 50 million RMB. It is committed to research & development, production and sales. Main business including :APIs, intermediates, CDMO, formulation. Manufacture site located in Kaifeng, Henan province with the area of 350 thousand squameters and building area 14 thousand squameters, clean area 6 thousand squameters. Currently own Lyophilized powder for injecton, Tablet, powder injection, tablet, granular, API and intermediate manufacturing plants. annual production capacity of AIP over 300 mt and intermediates 360mt, polypeptide API 20kg and sterile API 10mt.
In order to expend CDMO business, manufacturing site in Lanzhou, Gansu province and Yancheng,Jiangsu province as well as the R&D center in Shanghai is under building. Be responsible for the customers, be responsible for the society,be responsible for the employee, the company carried out 4 systems strictly: Quality system, EHS system,IP system well as drug administration system.
Basic Information
Tax ID
91410212744078206P
Country/Region
Henan, China
Year Established
2002
Registered Capital
CNY 50 Million
Business Type
CRO
Total Employees
100-500 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
It is a pharmaceutical technology enterprise integrating R & D, production and international sales, mainly engaged in small molecule API intermediates, CDMO and preparations.
PLANT LOCATION
ORGANIZATION UNIT
35 People
Production Dept
80 People
Analysis Dept
COMPANY ALBUM
CERTIFICATES